Sensex

Nifty

USDINR

GBPINR

EURINR

Wednesday, 24 April 2024 12:00 AM EOD	Asian-Paints2867.30	Axis-Bank1063.70	Bajaj-Finance7327.70	Bajaj-Finserv1630.45	Bharti-Airtel1336.25	HCL-Technologies1479.65	HDFC-Bank1510.95	Hind-Unilever2259.15	ICICI-Bank1096.85	IndusInd-Bank1474.65	Infosys1431.85	ITC428.85	JSW-Steel883.00	Kotak-Mah-Bank1843.05	Larsen-and-Toubro3634.95	M-and-M2059.25	Maruti-Suzuki12939.95	Nestle-India2502.90	NTPC351.55	Power-Grid-Corpn290.55	Reliance-Industr2900.60	St-Bk-of-India773.20	Sun-PharmaInds1486.35	Tata-Motors991.60	Tata-Steel165.50	TCS3831.25	Tech-Mahindra1186.10	Titan-Company3607.55	UltraTech-Cem9657.85	Wipro460.20
15 mins delay SENSEX 73,852.94 [114.49]	-7.05 -0.25%	7.25 0.69%	68.45 0.94%	10.00 0.62%	-6.05 -0.45%	-6.95 -0.47%	3.75 0.25%	-3.60 -0.16%	6.60 0.61%	0.95 0.06%	-9.85 -0.68%	-0.35 -0.08%	31.70 3.72%	29.80 1.64%	25.00 0.69%	-3.05 -0.15%	-53.75 -0.41%	3.35 0.13%	4.65 1.34%	5.55 1.95%	-17.90 -0.61%	0.35 0.05%	2.60 0.18%	5.00 0.51%	4.40 2.73%	-42.95 -1.11%	-14.00 -1.17%	-22.10 -0.61%	126.75 1.33%	-1.80 -0.39%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Aurobindo Pharma slides after promoter pares stake

17-Jun-21 11:09Hrs IST

Following the transaction, Kambam Spoorthi has decreased its stake in Aurobindo Pharma to 1.195% from 1.297% held earlier.

Shares of Aurobindo Pharma were trading 0.77% lower at Rs 980.15 on BSE.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. On a consolidated basis, Aurobindo Pharma posted 7.18% decline in net profit to Rs 801.1 crore on 1.18% decline in net sales to Rs 5,991.68 crore in Q4 FY21 over Q4 FY20.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

A Muthoot M George Enterprise